Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heterobicyclic carboxamides as inhibitors for kinases

Heterobicyclic carboxamides as inhibitors for kinases

US Patent 8133886 · Granted Mar 13, 2012

Estimated economic value: $18,572,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds and compositions for inhibiting the activity of HIF2-alpha and their m2025
Pyrazolyl derivatives useful as anti-cancer agents2023
Pyrazolo pyrimidine derivatives and their use as MALT1 inhbitors2019
Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL12018
Imidazopyrrolidine derivatives and their use in the treatment of disease2018
Imidazopyrrolidine derivatives and their use in the treatment of disease2018
Pyrazolo pyrimidine derivatives and their use as MALT1 inhibitors2017
Pyrazolo-pyrrolidin-4-one derivatives as bet inhibitors and their use in the tre2017
Pyrazolo[3,4-d]pyrimidinone compounds as inhibitors of the P53/MDM2 interaction2017
Pyrrolopyrrolone derivatives and their use as BET inhibitors2017
Pyrrolopyrrolone derivatives and their use as BET inhibitors2017
Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL2016